NO991198L - FremgangsmÕte ved fremstilling av et plasmaproteinholdig legemiddel - Google Patents

FremgangsmÕte ved fremstilling av et plasmaproteinholdig legemiddel

Info

Publication number
NO991198L
NO991198L NO991198A NO991198A NO991198L NO 991198 L NO991198 L NO 991198L NO 991198 A NO991198 A NO 991198A NO 991198 A NO991198 A NO 991198A NO 991198 L NO991198 L NO 991198L
Authority
NO
Norway
Prior art keywords
plasma
plasma protein
drug
citrate
preparation
Prior art date
Application number
NO991198A
Other languages
English (en)
Other versions
NO991198D0 (no
Inventor
Wolfgang Teschner
Yendra Linnau
Sonja Svatos
Herwig Igel
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3517640&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO991198(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of NO991198D0 publication Critical patent/NO991198D0/no
Publication of NO991198L publication Critical patent/NO991198L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Det er beskrevet en fremgangsmåte ved fremstilling av et plasmaproteinholdig legemiddel fra sitratplasma eller en sitratholdig plasmafraksjon, hvilket legemiddel er i det vesentlige fri for uønskede metaller, hvilken fremgangsmåte omfatter følgende trinn: utbytting av øitratet og eventuelt sitratbundet metall i en plasmaproteinholdig løsning med et vannløselig mono- eller dikarboksylat eller en organisk mono- eller dikar- boksylsyre under ikke-presipiterende betingelser; ekstraksjon av plasmaproteinet eller plasmaproteinene, og - ferdigstillelse av legemiddelet.
NO991198A 1996-09-16 1999-03-11 FremgangsmÕte ved fremstilling av et plasmaproteinholdig legemiddel NO991198L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0163396A AT403989B (de) 1996-09-16 1996-09-16 Verfahren zur herstellung eines plasmaprotein-hältigen arzneimittels
PCT/AT1997/000197 WO1998012225A2 (de) 1996-09-16 1997-09-10 Verfarhen zur herstellung eines plasmaprotein-hältigen arzneimittels

Publications (2)

Publication Number Publication Date
NO991198D0 NO991198D0 (no) 1999-03-11
NO991198L true NO991198L (no) 1999-05-14

Family

ID=3517640

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991198A NO991198L (no) 1996-09-16 1999-03-11 FremgangsmÕte ved fremstilling av et plasmaproteinholdig legemiddel

Country Status (24)

Country Link
US (3) US20020034809A1 (no)
EP (1) EP0927195B1 (no)
JP (1) JP2001500867A (no)
KR (1) KR20000036002A (no)
CN (1) CN1230967A (no)
AR (1) AR009582A1 (no)
AT (2) AT403989B (no)
AU (1) AU732519B2 (no)
BR (1) BR9712044A (no)
CA (1) CA2265936C (no)
CZ (1) CZ91199A3 (no)
DE (1) DE59710700D1 (no)
DK (1) DK0927195T3 (no)
ES (1) ES2206701T3 (no)
HU (1) HUP0002265A3 (no)
ID (1) ID21224A (no)
IL (1) IL128770A0 (no)
IN (1) IN187314B (no)
MX (1) MXPA99002144A (no)
NO (1) NO991198L (no)
PL (1) PL332159A1 (no)
PT (1) PT927195E (no)
SK (1) SK32899A3 (no)
WO (1) WO1998012225A2 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2103236B1 (es) * 1996-01-30 1998-04-16 Grifols Grupo Sa Albumina humana terapeutica con baja capacidad para la fijacion de aluminio.
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
AT408946B (de) * 1999-02-18 2002-04-25 Immuno Ag Verwendung von orosomucoid zur herstellung einer pharmazeutischen präparation
JP2003040798A (ja) * 2001-07-26 2003-02-13 Nihon Pharmaceutical Co Ltd 低アルミニウム含有アルブミン製剤およびその製造法
AU2002351756A1 (en) 2001-12-21 2003-07-15 Novo Nordisk Health Care Ag Liquid composition of factor vii polypeptides
AT501088A2 (de) * 2002-12-18 2006-06-15 Bio Prod & Bio Eng Ag Stabile therapeutische proteine
US7897734B2 (en) 2003-03-26 2011-03-01 Novo Nordisk Healthcare Ag Method for the production of proteins
MXPA05012476A (es) * 2003-05-23 2006-02-22 Novo Nordisk Healthcare Ag Estabilizacion de proteina en solucion.
BRPI0413518A (pt) 2003-08-14 2006-10-10 Novo Nordisk Healthcare Ag composição farmacêutica lìquida aquosa, método para preparar e uso da mesma, método para tratar uma sìndrome responsiva ao fator vii, e, recipiente hermético
ES2294976B1 (es) * 2007-11-12 2008-12-16 Grifols, S.A. "procedimiento de obtencion de albumina humana de alta eficacia para su uso en terapia de detoxificacion".
MX354995B (es) 2011-12-05 2018-03-27 Factor Bioscience Inc Metodos y productos para transfeccion de celulas.
ES2381828B1 (es) * 2012-03-20 2012-11-16 Grifols, S.A. PROCEDIMIENTO PARA OBTENER UNA COMPOSICION DE IgG MEDIANTE TRATAMIENTO TERMICO
JP7097433B2 (ja) 2017-08-17 2022-07-07 ジャスト－エヴォテック バイオロジックス、インコーポレイテッド 宿主細胞ガレクチンおよび他の夾雑物からグリコシル化タンパク質を精製する方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE384134C (de) * 1921-05-07 1923-10-25 Chemisch Pharmazeutische Werke Verfahren zur Herstellung eines Kamillenextraktes
DE2331854A1 (de) * 1973-06-22 1975-01-16 Greither Salus Haus Dr Otto Verfahren zur herstellung standardisierter arzneimittel aus kamillenblueten
FR2630115B1 (fr) 1988-04-14 1994-10-28 Merieux Inst Procede de stabilisation des solutions d'albumine humaine et solution obtenue
SE500110C2 (sv) 1989-06-27 1994-04-18 Kabi Pharmacia Ab Sätt att rena ett protein från därtill bundna flervärda metalljoner
US5250663A (en) * 1990-04-19 1993-10-05 Miles Inc. Preparing essentially monomeric normal human serum albumin
JP2949846B2 (ja) 1990-11-30 1999-09-20 吉富製薬株式会社 アルブミン製剤の保存方法
US5561115A (en) * 1994-08-10 1996-10-01 Bayer Corporation Low temperature albumin fractionation using sodium caprylate as a partitioning agent
ES2103236B1 (es) 1996-01-30 1998-04-16 Grifols Grupo Sa Albumina humana terapeutica con baja capacidad para la fijacion de aluminio.
US5744586A (en) * 1996-06-26 1998-04-28 Alpha Therapeutic Corporation Manufacturing process for the production of purified transferrin
US5886154A (en) 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies

Also Published As

Publication number Publication date
ATA163396A (de) 1997-12-15
PT927195E (pt) 2004-01-30
JP2001500867A (ja) 2001-01-23
AR009582A1 (es) 2000-04-26
WO1998012225A2 (de) 1998-03-26
MXPA99002144A (es) 2005-04-28
CZ91199A3 (cs) 1999-06-16
ATE248857T1 (de) 2003-09-15
PL332159A1 (en) 1999-08-30
US20140234292A1 (en) 2014-08-21
HUP0002265A2 (hu) 2000-11-28
US20050249815A1 (en) 2005-11-10
EP0927195A2 (de) 1999-07-07
IN187314B (no) 2002-03-23
AT403989B (de) 1998-07-27
EP0927195B1 (de) 2003-09-03
KR20000036002A (ko) 2000-06-26
HUP0002265A3 (en) 2003-01-28
ID21224A (id) 1999-05-06
US8709492B2 (en) 2014-04-29
AU4289997A (en) 1998-04-14
CA2265936C (en) 2008-04-22
IL128770A0 (en) 2000-01-31
AU732519B2 (en) 2001-04-26
NO991198D0 (no) 1999-03-11
SK32899A3 (en) 1999-08-06
ES2206701T3 (es) 2004-05-16
CN1230967A (zh) 1999-10-06
DE59710700D1 (de) 2003-10-09
CA2265936A1 (en) 1998-03-26
WO1998012225A3 (de) 1998-04-23
BR9712044A (pt) 1999-08-24
US20020034809A1 (en) 2002-03-21
DK0927195T3 (da) 2003-11-24

Similar Documents

Publication Publication Date Title
NO991198L (no) FremgangsmÕte ved fremstilling av et plasmaproteinholdig legemiddel
Rhoads et al. Purification and properties of collagen proline hydroxylase from newborn rat skin
Wahlestedt et al. Electroconvulsive shocks increase the concentration of neocortical and hippocampal neuropeptide Y (NPY)-like immunoreactivity in the rat
Trivedy et al. Copper stimulates human oral fibroblasts in vitro: a role in the pathogenesis of oral submucous fibrosis
DE60111247D1 (de) Verfahren für die produktion von peptiden unter verwendung eines in vitro transkription/translation system
EP1987843A3 (en) Method for solubilising peptide mixtures
JPS56135418A (en) Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human
PT1146896E (pt) Formulacoes monodispersas de analogo acilado e hexamerico insulina
ATE255646T1 (de) Verfahren zur wärmebehandlung von strukturgussteilen aus einer dafür zu verwendenden aluminiumlegierung
ATE358139T1 (de) Verfahren zur herstelllung von gonadotropin- zusammensetzungen
ATE83242T1 (de) Cysteinreiche, gamma-glutaminsaeure und betaalanin-einheitenaufweisende peptide, verfahren zu deren herstellung und ihre verwendung.
EA199700196A1 (ru) Способ получения фактора ix из биологических источников и фактор ix, полученный этим способом
Liao et al. Prostate alpha-protein. Complete amino acid sequence of the component that inhibits nuclear retention of the androgen-receptor complex.
du Vigneaud The role which insulin has played in our concept of protein hormones, and a consideration of certain phases of the chemistry of insulin
Decock-Le Reverend et al. Some aspects of the thioether donation in aminoacids and peptides complexes
EP1111533A3 (en) Logistic regression trees for drug analysis
Cantürk et al. The role of L-arginine and neutrophils on incisional wound healing
WO2002082092A3 (de) Bestimmung der wirksamen parathormon-aktivität in einer probe
Imai et al. A possible function of thiols, including glutathione, as cofactors in the conversion of thyroxine to 3, 3', 5-triiodothyronine in rat liver microsomes
RU2077779C1 (ru) Способ безотходной гидрометаллургической переработки стружковых отходов сплава алюминий-медь-олово
RU2001108801A (ru) Способ профилактики и лечения желчекаменной болезни
DK0946563T3 (da) Fremgangsmåde til udvinding af hæmatitjern fra slagteblod
Gubenko et al. Nature of Microfractures Close to Sulphide Inclusions in Steel During Deformation After Laser Treatment
ATE430723T1 (de) Verfahren zur oxidaton von xylen-derivaten
EA200000444A1 (ru) Способ удаления богатых азотом включений в титане и его сплавах

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application